Evidence map›Paper›PMID 27578529›Full record

ArticleScientific reports2016

Large-Scale Discovery of Disease-Disease and Disease-Gene Associations.

Djordje Gligorijevic, Jelena Stojanovic, Nemanja Djuric, Vladan Radosavljevic, Mihajlo Grbovic, Rob J Kulathinal, Zoran Obradovic

Abstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Exploring novel disease-disease associations based on multi-view fusion network.Computational and structural biotechnology journal · 2023
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Optimizing clinical trials recruitment via deep learning.Journal of the American Medical Informatics Association : JAMIA · 2019
    Article
  14. Article
  15. Reforming disease classification system-are we there yet?Annals of translational medicine · 2018
    Article
  16. Opportunities and obstacles for deep learning in biology and medicine.Journal of the Royal Society, Interface · 2018
    Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Djordje GligorijevicCenter for Data Analytics and Biomedical Informatics, Temple University, Philadelphia, PA 19122 USA.
Jelena StojanovicCenter for Data Analytics and Biomedical Informatics, Temple University, Philadelphia, PA 19122 USA.
Nemanja DjuricCenter for Data Analytics and Biomedical Informatics, Temple University, Philadelphia, PA 19122 USA.
Vladan RadosavljevicCenter for Data Analytics and Biomedical Informatics, Temple University, Philadelphia, PA 19122 USA.
Mihajlo GrbovicCenter for Data Analytics and Biomedical Informatics, Temple University, Philadelphia, PA 19122 USA.
Rob J KulathinalDepartment of Biology, Temple University, Philadelphia, PA 19122 USA.
Zoran ObradovicCenter for Data Analytics and Biomedical Informatics, Temple University, Philadelphia, PA 19122 USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Data-driven phenotype analyses on Electronic Health Record (EHR) data have recently drawn benefits across many areas of clinical practice, uncovering new links in the medical sciences that can potentially affect the well-being of millions of patients. In this paper, EHR data is used to discover novel relationships between diseases by studying their comorbidities (co-occurrences in patients). A novel embedding model is designed to extract knowledge from disease comorbidities by learning from a large-scale EHR database comprising more than 35 million inpatient cases spanning nearly a decade, revealing significant improvements on disease phenotyping over current computational approaches. In addition, the use of the proposed methodology is extended to discover novel disease-gene associations by including valuable domain knowledge from genome-wide association studies. To evaluate our approach, its effectiveness is compared against a held-out set where, again, it revealed very compelling results. For selected diseases, we further identify candidate gene lists for which disease-gene associations were not studied previously. Thus, our approach provides biomedical researchers with new tools to filter genes of interest, thus, reducing costly lab studies.

Indexed as

Electronic Health RecordsGenetic Predisposition to DiseaseAlgorithmsDatabases, FactualGenetic Diseases, InbornGenome-Wide Association StudyHumansPhenotype

Identifiers

PMID27578529
PMCPMC5006166

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.